Skip to main content
Log in

Association between C-reactive protein and QTc interval in middle-aged men and women

  • Cardiovascular Diseases
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Background

Both of prolonged QT interval and elevated C-reactive protein (CRP) levels are known to be risk factors of cardiovascular disease. To our knowledge, few studies have reported the direct relationship between CRP levels and the QT interval in middle-aged population. The objective of the present study was to examine the association of CRP level with QT interval.

Methods and results

A total of 2471 men and 2287 women from the Korea n Health and Genome study underwent physical examination and completed a questionnaire. A 12-lead electrocardiogram (ECG) recording was obtained from each subject. Subjects who were taking statins, non-steroidal anti-inflammatory drugs (NSAID) and postmenopausal hormone replacement therapy, which are known to have an effect on CRP levels, were excluded. Geometric means of CRP levels were compared among three groups, which were classified by heart rate-corrected QT (QTc) interval: prolonged (≥440 msec in men and ≥450 msec in women), borderline (420–439 msec in men and 430–449 msec in women) and normal (<420 msec in men and <430 msec in women) groups. The means of CRP level in women, though over normal range, increased significantly as QTc interval was longer, independent of confounding factors, while those of men were on the borderline of significance. However, compared to normal range of QTc interval, prolonged QTc interval was associated with elevated CRP level, defined as more than 95 percentile of CRP, in men and women, respectively.

Conclusions

Prolonged QTc interval in middle-aged men and women is associated with the elevated CRP, independent of confounding factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

BMI:

body-mass index

CRP:

C-reactive protein

ECG:

electrocardiogram

HDL:

high-density lipoprotein

NSAID:

non-steroidal anti-inflammatory drug

QTc:

heart rate-corrected QT

Reference

  1. Lepeschkin E, Surawicz B (1952). Measurement of the QT interval of the electrocardiogram. Circulation 6:378–388

    PubMed  CAS  Google Scholar 

  2. Tan HL, Hou CJ, Lauer MR, Sung RJ (1995) Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes. Ann Intern Med 122:701–714

    PubMed  CAS  Google Scholar 

  3. Moss AJ (1993). Measurement of the QT interval and the risk associated with QTc interval prolongation: A review. Am J Cardiol 72:23B–25B

    Article  PubMed  CAS  Google Scholar 

  4. Schwartz PJ, Wolf S (1978). QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 57:1074–1077

    PubMed  CAS  Google Scholar 

  5. Dekker JM, Crow RS, Hannan PJ, Schouten EG, Folsom AR (2004). Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: The ARIC study. J Am Coll Cardiol 43:565–571

    Article  PubMed  Google Scholar 

  6. Robbins J, Nelson JC, Rautaharju PM, Gottdiener JS (2003). The association between the length of the QT interval and mortality in the Cardiovascular Health Study. Am J Med 115:689–694

    Article  PubMed  Google Scholar 

  7. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J (1991). QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 84:1516–1523

    PubMed  CAS  Google Scholar 

  8. Busjahn A, Knoblauch H, Faulhaber HD, et al. (1999) QT interval is linked to 2 long-QT syndrome loci in normal subjects. Circulation 99:3161–3164

    PubMed  CAS  Google Scholar 

  9. Woosley RL, Sale M (1993). QT interval: A measure of drug action. Am J Cardiol 72:36B–43B

    Article  PubMed  CAS  Google Scholar 

  10. Ahnve S, Vallin H (1982). Influence of heart rate and inhibition of autonomic tone on the QT interval. Circulation 65:435–439

    PubMed  CAS  Google Scholar 

  11. Magnano AR, Holleran S, Ramakrishnan R, Reiffel JA, Bloomfield DM (2002). Autonomic nervous system influences on QT interval in normal subjects. J Am Coll Cardiol 39:1820–1826

    Article  PubMed  Google Scholar 

  12. Nakagawa M, Ooie T, Ou B, et al. (2005) Gender differences in autonomic modulation of ventricular repolarization in humans. J Cardiovasc Electrophysiol 16:278–284

    Article  PubMed  Google Scholar 

  13. Bellavere F, Ferri M, Guarini L, et al. (1988) Prolonged QT period in diabetic autonomic neuropathy: A possible role in sudden cardiac death?. Br Heart J 59:379–383

    PubMed  CAS  Google Scholar 

  14. Glickstein JS, Schwartzman D, Friedman D, Rutkowski M, Axelrod FB (1993). Abnormalities of the corrected QT interval in familial dysautonomia: An indicator of autonomic dysfunction. J Pediatr 122:925–928

    Article  PubMed  CAS  Google Scholar 

  15. Diedrich A, Jordan J, Shannon JR, Robertson D, Biaggioni I (2002). Modulation of QT interval during autonomic nervous system blockade in humans. Circulation 106:2238–2243

    Article  PubMed  Google Scholar 

  16. Du Clos TW (2000). Function of C-reactive protein. Ann Med 32:274–278

    PubMed  CAS  Google Scholar 

  17. Gabay C, Kushner I (1999). Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–454

    Article  PubMed  CAS  Google Scholar 

  18. Danesh J, Wheeler JG, Hirschfield GM, et al. (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387–1397

    Article  PubMed  CAS  Google Scholar 

  19. Koenig W, Sund M, Frohlich M, et al. (1999) C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99:237–242

    PubMed  CAS  Google Scholar 

  20. Tracy RP, Lemaitre RN, Psaty BM, et al. (1997) Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 17:1121–1128

    PubMed  CAS  Google Scholar 

  21. Pearson TA, Mensah GA, Alexander RW, et al. (2003) Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499–511

    Article  PubMed  Google Scholar 

  22. Borovikova LV, Ivanova S, Zhang M, et al. (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458–462

    Article  PubMed  CAS  Google Scholar 

  23. Tracey KJ (2002). The inflammatory reflex. Nature 420:853–859

    Article  PubMed  CAS  Google Scholar 

  24. Janszky I, Ericson M, Lekander M, et al. (2004) Inflammatory markers and heart rate variability in women with coronary heart disease. J Intern Med 256:421–428

    Article  PubMed  CAS  Google Scholar 

  25. Malave HA, Taylor AA, Nattama J, Deswal A, Mann DL (2003). Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: A study in patients with mild-to-moderate heart failure. Chest 123:716–724

    Article  PubMed  CAS  Google Scholar 

  26. Kazumi T, Kawaguchi A, Hirano T, Yoshino G (2003). C-reactive protein in young, apparently healthy men: Associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol. Metabolism 52:1113–1116

    Article  PubMed  CAS  Google Scholar 

  27. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF (2004). Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 25:363–370

    Article  PubMed  Google Scholar 

  28. Shin C, Abbott RD, Lee H, Kim J, Kimm K (2004). Prevalence and correlates of orthostatic hypotension in middle-aged men and women in Korea: The Korean Health and Genome Study. J Hum Hypertens 18:717–723

    Article  PubMed  CAS  Google Scholar 

  29. Shin C, Lee S, Abbott RD, et al. (2004) Respiratory symptoms and undiagnosed airflow obstruction in middle-aged adults: The Korean Health and Genome Study. Chest 126:1234–1240

    Article  PubMed  Google Scholar 

  30. Albert MA, Danielson E, Rifai N, Ridker PM (2001). Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation/CRP evaluation (PRINCE): A randomized trial and cohort study. JAMA 286:64–70

    Article  PubMed  CAS  Google Scholar 

  31. Kluft C, Leuven JA, Helmerhorst FM, Krans HM (2002). Pro-inflammatory effects of oestrogens during use of oral contraceptives and hormone replacement treatment. Vascul Pharmacol 39:149–154

    Article  PubMed  CAS  Google Scholar 

  32. Laiho K, Belt E, Maenpaa H, Kautiainen H, Kauppi M (2001). Effect of daily corticosteroid treatment on CRP response to hip or knee replacement in patients with RA. Ann Rheum Dis 60:989

    Article  PubMed  CAS  Google Scholar 

  33. Bazett H (1920). An analysis of time relations of the electrocardiograms. Heart 7:353–367

    Google Scholar 

  34. WHO (2004). Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163

    Article  Google Scholar 

  35. Alberti KG, Zimmet PZ (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15:539–553

    Article  PubMed  CAS  Google Scholar 

  36. Chobanian AV, Bakris GL, Black HR, et al. (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42:1206–1252

    Article  PubMed  CAS  Google Scholar 

  37. Macfarlane PW (2000). Minnesota coding and the prevalence of ECG abnormalities. Heart 84:582–584

    Article  PubMed  CAS  Google Scholar 

  38. Lane PW, Nelder JA (1982). Analysis of covariance and standardization as instances of prediction. Biometrics 38:613–621

    Article  PubMed  CAS  Google Scholar 

  39. Roden DM, Spooner PM (1999). Inherited long QT syndromes: A paradigm for understanding arrhythmogenesis. J Cardiovasc Electrophysiol 10:1664–1683

    PubMed  CAS  Google Scholar 

  40. Roden DM (2004). Drug-induced prolongation of the QT interval. N Engl J Med 350:1013–1022

    Article  PubMed  CAS  Google Scholar 

  41. Peters RW, Byington RP, Barker A, Yusuf S (1990). Prognostic value of prolonged ventricular repolarization following myocardial infarction: The BHAT experience. The BHAT Study Group. J Clin Epidemiol 43:167–172

    Article  PubMed  CAS  Google Scholar 

  42. Brown DW, Giles WH, Greenlund KJ, Valdez R, Croft JB (2001). Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. J Cardiovasc Risk 8:227–233

    Article  PubMed  CAS  Google Scholar 

  43. Dekker JM, Feskens EJ, Schouten EG, Klootwijk P, Pool J, Kromhout D (1996). QTc duration is associated with levels of insulin and glucose intolerance. The Zutphen Elderly Study. Diabetes 45:376–380

    PubMed  CAS  Google Scholar 

  44. Gastaldelli A, Emdin M, Conforti F, Camastra S, Ferrannini E (2000). Insulin prolongs the QTc interval in humans. Am J Physiol Regul Integr Comp Physiol 279:R2022–R2025

    PubMed  CAS  Google Scholar 

  45. Carella MJ, Mantz SL, Rovner DR, et al. (1996) Obesity, adiposity, and lengthening of the QT interval: Improvement after weight loss. Int J Obes Relat Metab Disord 20:938–942

    PubMed  CAS  Google Scholar 

  46. Madden K (2001). Catecholamines, sympathetic nerves and immunity. In: Ader R, Felten D, Cohen N, (eds) Psychoneuroimmunology 3rd ed. New York, Academic Press, pp. 197–216

    Google Scholar 

  47. Aronson D, Mittleman MA, Burger AJ (2001). Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J Cardiovasc Electrophysiol 12:294–300

    Article  PubMed  CAS  Google Scholar 

  48. Jensen-Urstad M, Jensen-Urstad K, Ericson M, Johansson J (1998). Heart rate variability is related to leucocyte count in men and to blood lipoproteins in women in a healthy population of 35-year-old subjects. J Intern Med 243:33–40

    Article  PubMed  CAS  Google Scholar 

  49. Goldman MJ. Principles of Clinical Electrocardiography, 8th edn. In: Los Altos (ed), Lange Medical Publications, California 1973: 24–28

  50. Lepeschkin E. Mordern Electrocardiography. Vol. 1. Williams and Wilkins, Baltimore, MD, 1951

Download references

Acknowledgements

This study was supported by Center for Genome Science, Korea National Institute of Health, (Budgets 2001-347-6111-221 and 2002-347-6111-221).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chol Shin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, E., Joo, S., Kim, J. et al. Association between C-reactive protein and QTc interval in middle-aged men and women. Eur J Epidemiol 21, 653–659 (2006). https://doi.org/10.1007/s10654-006-9034-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-006-9034-9

Keywords

Navigation